Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.

The approach relies on “reprogramming” cells to a younger state. It’s one of many strategies being explored by biotech ...

First human receives reverse-aging gene therapy in groundbreaking trial targeting glaucoma, using cellular reprogramming to ...

The world's first reverse aging drug, ER-100, was injected into a human on June 9, 2026 The post The World’s First ...

Test time has arrived: the first person has been treated in a highly anticipated gene therapy trial that aims to coax aged ...

As AI transforms biology, longevity startups are attracting investors, advancing toward clinical milestones, and reshaping ...

Reversing cellular age isn’t science fiction, but the biology is more complicated than either the skeptics or the hype ...

Biotech startup NewLimit secures a major funding round after claiming a ‘breakthrough discovery’ of a prototype medicine that ...

In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the "recipe" for the transformation. Researchers at Lund University have now created ...

Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...

A participant in a landmark clinical trial has been given a cellular-reprogramming treatment that aims to rejuvenate damaged ...